Therapeutic, prophylactic, and functional use of probiotics: A current perspective
Protecting yourself requires knowing the warning signs that indicate a provider may be unsafe, illegitimate, or operating outside appropriate medical and pharmaceutical boundaries
On paper that sounds like a contradiction, and at high doses it would be
You start a GLP-1 medication expecting appetite suppression, weight loss, maybe some nausea
Within the clinical trial setting, retatrutide has been associated with a range of adverse effects, the majority of which are gastrointestinal in nature
July 2324, 2026: The FDAs Pharmacy Compounding Advisory Committee (PCAC) met and voted on seven peptides being considered for the Category 1 list